Phase 2 trial of Oxford Covid-19 vaccine candidate set to begin today

The observer-blind, randomised controlled study to determine the safety and immunogenicity of ‘‘Covishield’‘ on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.

from Hindustan Times - india https://ift.tt/3jfglOv